Empire Financial Management Company’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $479K | Sell |
5,775
-450
| -7% | -$37.3K | 0.14% | 146 |
|
|
2025
Q1 | $505K | Sell |
6,225
-900
| -13% | -$73K | 0.16% | 141 |
|
|
2024
Q4 | $642K | Sell |
7,125
-12,882
| -64% | -$1.16M | 0.2% | 126 |
|
|
2024
Q3 | $1.98M | Buy |
20,007
+629
| +3% | +$62.1K | 0.61% | 55 |
|
|
2024
Q2 | $1.8M | Buy |
19,378
+1,558
| +9% | +$144K | 0.59% | 56 |
|
|
2024
Q1 | $1.69M | Buy |
17,820
+2,474
| +16% | +$235K | 0.56% | 61 |
|
|
2023
Q4 | $1.37M | Buy |
15,346
+1,035
| +7% | +$92.4K | 0.54% | 57 |
|
|
2023
Q3 | $1.04M | Sell |
14,311
-1,738
| -11% | -$127K | 0.46% | 64 |
|
|
2023
Q2 | $1.34M | Sell |
16,049
-140
| -0.9% | -$11.6K | 0.53% | 56 |
|
|
2023
Q1 | $1.23M | Buy |
+16,189
| New | +$1.23M | 0.5% | 62 |
|